Approaches sponsors, CROs, and investigators can take from the DMD experience.
Michael G. Kelly, PhD
Advertisement
Chief Scientific Officer, CureDuchenne
Articles by Michael G. Kelly, PhD
Advertisement
Latest Updated Articles
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating AI Across Legacy Clinical Trial Systems
2
Reimagining Clinical Operations Through Artificial Intelligence
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
